Teradata (NYSE:TDC – Free Report) had its target price cut by Evercore ISI from $37.00 to $32.00 in a research report report ...

In a report released yesterday, Amit Daryanani from Evercore ISI maintained a Buy rating on Vertiv Holdings (VRT – Research Report), with a ...

Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (NasdaqGM:CRSP) from In-Line to Outperform. Analyst Price Forecast Suggests 90.46% Upside As ...

Travere Therapeutics (NASDAQ:TVTX – Free Report) had its price target hoisted by Evercore ISI from $33.00 to $45.00 in a research note released on Wednesday,Benzinga reports. The brokerage currently ...

In a report released yesterday, Stephen Richardson from Evercore ISI initiated coverage with a Buy rating on Flowco Holdings Inc Class A (FLOC ...

Evercore ISI maintained its positive stance on ARM Holdings (LON:ARM) stock, raising the price target to $202.00 from the previous $176.00, while reiterating an Outperform rating. The firm's analysts ...

Marriot International (NASDAQ:MAR) gained slightly in early action after Evercore ISI upgraded the hotel stock to an ...

Evercore ISI upgraded Marriott International (MAR ... it trades at a 10% discount to Hilton Worldwide Holdings (HLT, Financials). Marriott still commands a 20% premium over the S&P 500, down ...

Ari Bousbib; Chairman of the Board, Chief Executive Officer; IQVIA Holdings Inc Ronald Bruehlman; Chief Financial Officer, Executive Vice President; IQVIA Holdings Inc Shlomo Rosenbaum; Analyst; ...

Evercore ISI upgraded Marriott International (MAR, Financials) to Outperform from In-Line, citing robust travel demand, the ...